Fantastic Moffitt Cancer Center double act from Conor Lynch & @dbasanta presenting, The Role of the Bone Microenvironment in Multiple Myeloma Relapse and the Emergence of Resistance to Proteasome Inhibitors #CSBCPSON23 IMO
🔥super excited to share that I have just been awarded with a grant from DFG public | @[email protected] to study the genetics of autism spectrum and protein degradation machineries in the developing cortex! 🤩 ubiquitin and proteasome to the front! 🥽🥼🔬🧫
Through a combination of cell biology, biochemistry and time-resolved #proteomics during leaf development, we were able to uncover the involvement of proteasome activity and endoreduplication in this phenotype.
🚨Excited to share that our manuscript is now published in NatureStructMolBiol. Using #cryoEM 🔬we obtained multiple snapshots 📷 of the #chaperone -mediated multistep assembly pathway of the human 20S #proteasome .
Max Planck Institute of Biochemistry (MPIB) Harvard Med Cell Bio Aligning Science Across Parkinson’s
nature.com/articles/s4159…
Join us next week for #DegradoZoom on July 6th, 12pm EST:
Bernat Crosas Bernat Crosas IBMB: Development of proteolytic chimeras based on direct 26S proteasome targeting
Muhar Matthias Matthias Muhar ETH Zürich: A chemical degron marks C-terminally modified proteins for degradation
Join us for our last DegradoZoom of 2023, featuring University of Bonn's Radek Nowak Radek Nowak on 'Structure-based Design of Covalent Cereblon Binders' and Christian Steinebach Christian Steinebach on 'Targeting the Ubiquitin-Proteasome-System with PROTACs.' Thursday, Dec 14th, 11am EST
🎯Comprehensive Review
Development of Proteasome Inhibitors for Cancer Therapy
Scilight Science #MedEd #MedX #pharmaceutical #Pharmacology #Science #review #oncology #CancerResearch #Proteasome
sciltp.com/journals/ijddp…